Utility of chromogranin A, pancreatic polypeptide, glucagon, and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients

OBJECTIVE: Pancreatic neuroendocrine tumors (PNETs) are the major source of disease-specific mortality in multiple endocrine neoplasia type 1 (MEN1) patients. Chromogranin A (CgA), pancreatic polypeptide (PP), glucagon, and gastrin have some diagnostic value in sporadic PNETs, but there is very litt...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Endocrinol (Oxf)
Auteurs principaux: Qiu, Wei, Christakis, Ioannis, Silva, Angelica, Bassett, Roland L., Cao, Liyun, Meng, Qing H., Grubbs, Elizabeth Gardner, Zhao, Hua, Yao, James C., Lee, Jeffrey E., Perrier, Nancy D.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4988913/
https://ncbi.nlm.nih.gov/pubmed/27256431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13119
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires